Ahamed, M., Alsalhi, M.S. and Siddiqui, M. 2010. Silver nanoparticle applications and human health. – Inter. J. Clinic. Chem. 411: 1841-1848.
Amirkhani-Dehkordi, Z., Naghsh, N., Nuri, A. and Agha-baba, H. 2013. Comparison of injective and contact ef-fect of silver nanoparticles on the rate of hemoglobin ch-anges in male rats. – Hakim Seyed Esmail Jorjani J. 14: 38-43.
Cai, Z., Barry, C.E. and Huner, Z.B. 2006. Mechanism of action of isoniazid. – Mol. Microb. 62: 1220-1227.
Christoforidis, G., Frank, J., Lindau, M., Lockman, G., Jones, C. and Petricoin, E. 2006. Nanoparticles: pote-ntial biomarker harvesters. – Curr. Opin. Chem. Biol. 10: 56-61.
Eom, H.J. and Choi, J. 2010. P 38 MAPK activation, DNA damage, cell cycle arrest and apoptosis as mechanisms of toxicity of silver nanoparticles in Jurkat T cells. – Envi-ron. Sci. Technol. 44: 8337-8342.
Fukuoka, A., Sakamoto, Y. and Guan, S. 2001. Novel te-mplating synthesis of necklace shaped mono and bi-metallic nanowires in hybrid organic inorganic me-soporous material. – Jam Chem. 123: 3373-3374.
Gajalakshmi, V., Peto, R., Kanaka, T.S. and Jha, P. 2003. Smoking and mortality from tuberculosis and other dise-ases in India: retrospective study of 43000 adult male de-aths and 35000 controls. – Lancet 362: 507-515.
Georgieva, N., Gadjeva, V. and Tolekova, A. 2004. New is-onicotinoylhydrazones with SSA protect against oxid-ative-hepatic injury of isoniazid. – TJS 2: 37-43.
Ghorbanzadeh, V., Moshtaghian, J. and Ebadi, A.H. 2011. Influence of nano-silver on graffian follicles via intr-aperitoneal injection in rats. – Middle-East J. Scien. Re-sea. 8: 228-230.
Gopinath, P., Gogoi, S.K., Sanpui, P., Paul, A., Chattopa-dhyay, A. and Ghosh, S.S. 2010. Signaling gene casc-ade in silver nanoparticle induced apoptosis. – Colloids and Surfaces B: Biointerfaces 77: 240-245.
Hooshiar, L. and Rezaei, S. 2010. The effect of silver na-noparticle on the ovarian tissue and hypophysis gonad axis on Wistar rat. – Thesis of MSC, PNU, Tehran. pp 1-20.
Huang, X., Choi, Y., Im, H. 2006. Aspartate aminotra-nsferase (AST/GOT) and alanine aminotransferase (ALT/GPT) detection techniques. – Sensors 6: 756-782.
Hussain, S., Hess, K., Gearhart, J., Geiss, K. and Schlager, J. 2005. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. – Toxicol. In vitro 19: 975-983.
Khodadadi‚ S., Naghsh‚ N. and Mashayekh, A. 2013. Ef-fects of silver nanoparticle on phospho creatine kinase and histological changes of skeletal muscle tissue in male Wistar rat. – Mazand. Univ. Med. Sci. J. 23: 36-41.
Liu, G., Men, P., Harris, P.L., Rolston, R.K., Perry, G., and Smith, M.A. 2006. Nanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace meta-l imbalance. – Neurosci. Let. 406:189-193.

Long, T.C., Saleh, N., Tilton, R.D., Lowry, G.V. and Vero-nesi, B. 2006. Titanium dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV2): implications for nanoparticle neurotoxicity. – Env. Sci. Technol. 40: 4346-4352.
Malekigorji, M., Curtis, A.D.M. and Hoskims, C. 2014. The use of Iron oxide nanoparticles for pancreatic cancer therapy. – J. Nanomed. Res. 1: 0004. Dol: 10.15406/ jnmr.2014.01.0004.
Mittler, R. 2002. Oxidative stress, antioxidants and stress tolerance. – Trends in Plant Sci. 7: 405-410.
Mohajeri, D., Doustar, Y. and Rahmani, J. 2011. Antiox-idant activity of green tea extract against Isoniazid in-duced hepatotoxicity in the rats. – Veterinary J. 5: 1221-1232.
Nel, A., Xia, T., Mädler, L. and Li, N. 2006. Toxic pote-ntial of materials at the nanolevel. – Sci. 311: 622-627.
Oberdörster, G., Stone, V. and Donaldson, K. 2007. Toxi-cology of nanoparticles: a historical perspective. – Nano-toxicol. 1: 2-25.
Ranjbar, A., Ataie, Z., Khajavi, F. and Ghasemi, H. 2013. Effects of silver nanoparticle on oxidative stress biom-arkers in rat. – Nanomed. J. 1: 205-211.
Razavian, M.H., Safarpour, E., Rohani, K., Yazdian, M.R. and Heidarian N. 2011. Study of some biochemical and hematological parameters changes of Wistar rats blood parallel to oral nanosilver consumption. – J. Babol Univ-ersity Med. Sci. 13: 22-27.
Rezaee Ranjbar Sardari, R., Rezaei Zarchi, S., Nasri, S., Talebi, A.R., Khoradmehr, A., Razavi Sheshde, A.R. and Adib, M. 2012. Toxicological effects of silver na-noparticles in rats lung. – Shahid Sadoughi Univ. Med. Sci. J. 20: 269- 276.
Stone, V. and Donaldson, K. 2006. Nanotoxicology: signs of stress. – Nature Nanotechnol. 1: 23-24.
Sukumaran, P. and Eldho, K.P. 2012. Silver nanopart-icles: mechanism of antimicrobial action, synthesis, me-dical applications, and toxicity effects. – Inter. Nano Lett.2:32 doi:10.1186/2228-5326-2-32.
Sun, Y., Oberley, L.W. and Li, Y. 1988. A simple method for clinical assay of superoxide dismutase. – Clinical Chem. 34: 497-500.
Tang, J. and Xi, T. 2008. Status of biological evaluation on silver nanoparticles. – Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 25: 958-961 (in Chinese).